This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As pharmaceutical reps are used less and less, the role of the MSL has become more prominent as a conduit between life sciences companies and external stakeholders for drug development.
Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. They are no longer “just” educating and informing doctors but helping to accelerate medicalscience innovation. Reference: 1. See resource here.
Medical Sales Reps have been on the scene since the year dot. The post Can MedicalScience Liaisons Improve Pharma Sales Effectiveness? appeared first on REVO.
AI was novel in pharma training in early 2024. For training leaders trying to cut through the noise, here are the five biggest trends shaping AI in pharma sales training in 2025. MSL Training Becomes More Strategic MedicalScience Liaisons (MSLs) play a critical role in bridging scientific data with clinical practice.
While the sales force is still a crucial part of any pharmaceutical company, the demand for Medical Affairs teams continue to rise. How are sales reps and MedicalScience Liaisons (MSLs) the same? Ways Pharma reps and MSLs are different: Typically, an MSL holds a doctorate degree, whether it be a PhD, MD, or PharmD.
Life sciences companies’ owned channels remain relevant. Pharma reps are especially critical when it comes to product information, with 55% of all U.S. physicians, 48% accessed product info through pharma HCP websites, a notable source of this type of content for endocrinologists (60%). Channel Use in Flux. Among all U.S.
Are you ready to explore the fascinating world of MedicalScience Liaisons (MSLs) in the pharmaceutical industry ? MSLs are considered the experts in scientific and medical information and they are responsible for building relationships with healthcare professionals.
Medical communications are in a state of transition. Due to the combined impact of emerging technologies, changing provider preferences, and an evolving post-pandemic world, pharma must navigate new ways to engage providers with relevant, science-driven, digital content.
This episode is packed with insights for anyone considering a career shift within medical sales or exploring entrepreneurial ventures. Discover the nuanced transition from pharma to the dynamic world of medical device sales, where understanding complex stakeholder landscapes is crucial.
At Pharma Customer Engagement Europe (20-22 April, Virtual) leaders unite to develop hybrid field force models, measure true digital effectiveness, and optimize content to make holistic customer engagement the norm and surpass HCP needs. Victoria Ho, Director, MedicalScience Liason Excellence, Jazz. SAVE YOUR SEAT!
LLM/generative AI is ideally suited to assist brand managers, customer experience professionals, and sales teams—medicalscience liaisons, too—with some of the heavy lifting to create, organize, and analyze customized content. But creating the high volumes of content that are required to personalize engagement is time consuming.
As what Harvard Business Review calls “a tidal wave of resignations” continues — with the highest rates for those ages 30-45 — and, as many pandemic-induced changes continue to alter to the structure of businesses worldwide (including pharma sales and marketing organizations) — many of our basic assumptions, approaches, and priorities need to shift.
The primary purpose of MedicalScience Liaison MSL is to establish and maintain peer-peer relationships with leading physicians, referred to as Key Opinion Leaders KOL’s, at major academic institutions and clinics. We have highlighted 5 quick tips for MSL to aid them through the process when engaging with KOL’s.
As medical treatments become more complex, the role of the MedicalScience Liaison (MSL) has never been more important. Healthcare professionals trust MSLs to keep them informed and up-to-date about the latest treatments, especially in fast-moving areas like oncology.
Seamless data sharing between clinical teams and medicalscience liaisons, for example, could greatly influence clinical trial site selection and ensure more coordinated engagement. Given the demand to deliver a steady stream of content to meet HCPs’ needs, pharma marketers must react, create, edit, and adapt quickly.
It's the secret sauce to thriving in the pharma industry. From cutting-edge training techniques that break the mold, to the latest industry trends making waves, and the career development hacks every pharma rep should know – we've got it all covered. Welcome to the world where sales training isn't just a formality.
Related: How AI and Innovation Are Reshaping Pharma Sales Training in 2025 Breaking Down Silos Between Teams Success in pharmaceutical sales training isnt just about individual performanceit depends on how well different teams work together.
Pharmaceutical sales representatives (often times referred to as pharma reps) are hired by pharmaceutical/biotech companies to educate healthcare providers (HCPs) such as physicians, pharmacists, nurses, and physician assistants (PAs) on their company’s product. What skills are necessary to become a pharma sales rep?
Medical publications are often highly valued by doctors because they are essential to their professional practice and continuous education. The main source of new and up-to-date information on medical research, clinical trials, treatment recommendations, and developments in medicalscience is medical journals.
Kaitlin Anstett , Senior Medical Advisor at Theratechnologies , will sit down with Natalie Yeadon , Co-founder & CEO of Impetus Digital , to share her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important stakeholders in the “new normal.” Sign up now!
What do you need to be successful in medical device sales? Not all folks have degrees in medicalsciences. Most biotech/pharma, require a four year undergraduate degree, big pharma especially. It’s also important to find the right company and product whether its pharma, vaccines, etc.
Acting as a go-between for pharma and physicians, medicalscience liaisons (MSLs) are responsible for communicating necessary information about new medicines to healthcare professionals and key opinion leaders (KOLs). As with many aspects of the medical world, they are now shifting online. A fresh approach.
In recent years, there has been an increased focus on real world evidence to advance medicalscience and improve patient quality of life. Biopharma companies are investing in the use of real world data (RWD) to accelerate innovation.
According to Veeva Pulse data , COVID-19 has accelerated the shift to digital for life sciences, with significant growth in remote and digital engagement since early 2020, and a 10X increase of HCPs using three or more channels in their engagement with pharma 1. Get stakeholder buy in on the “why”.
The pandemic has also disrupted how HCPs interact with their colleagues and pharma in sharing information. Where once pharma relied on reps and medicalscience liaisons (MSLs) to engage clinicians, many digital interactions, such as video conferencing, have replaced the need for in-person meetings.
Advance MedicalScience. Note that in each example, the EHR application is entirely and without interruption in the hands of the licensed and credentialed HCP at the clinic or hospital, and the EHR data are never in the hands of any third-party sponsor such as a biotech or pharma manufacturer.
Previously, he spent more than 10 years at Roche in multiple positions within medical affairs. He received an MD from the Georg August University of Göttingen and completed a postdoctoral Master’s in MedicalSciences Clinical Pharmacology at the University of Glasgow. Congressional Budget Office. cited 2023 Apr 4].
Healthcare providers (HCPs), payers, and patients can now access medical information at their fingertips and they expect more from Pharma than in the past. Nevertheless, some Pharma executives have been resistant to wholly embracing digital transformation. Evolution of the MSL Function Earlier this year, Peter J.
An MSL is a medically specialized representative for pharmaceutical companies. By outlining the product specifications, advising, and educating, they act as a bridge between pharma companies and their clients. This means that during the Q&A session, you may face a myriad of intricate medical, functional, or operational questions.
Derek Choy The Fine-Tuning API (Application Programming Interface) in OpenAI now enables the creation of hyper-personalized content to support brand managers, customer experience professionals, sales teams, and medicalscience liaisons.
MedicalScience Liaisons are hired or contracted to meet with these stakeholders prior to and during the launch and distribution period to educate and create awareness of the drug. This should clearly portray their motives, impact, and interests.
Combined with the incentives provided by the Orphan Drug Act, a powerful dynamic is at play, ever further pushing the limits of what medicalscience can achieve. Accelerating the Path to Diagnosis and Treatment. However, this bustling space also faces some unique challenges.
sales, medicalscience liaisons, etc.). So, no pressure… Rethinking brand launch and adoption cycles Now, amid a global pandemic with no clear end in sight, the launch process has become even harder.
“To remain at the forefront of medical research, pharma needs a faster, more predictive way of testing molecules before they go into humans,” says Steve Arlington, global life sciences industry advisor leader at PwC. “It’s very disappointing.
HCPs are pressed for time, eager to keep up with scientific and clinical developments, skeptical about big pharma, and increasingly focused on outcomes and metrics. million self-identified HCPs on the platform to pharma marketers. Look for TikTok to merchandise the 4.7
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content